Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06381921 · ClinicalTrials.gov registry record · NA
Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain
A NA study of Abdominal Pain, sponsored by University of Connecticut.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06381921: Recruiting NA study of Abdominal Pain, sponsored by University of Connecticut.
NCT06381921 is a NA study of Abdominal Pain that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 120 participants, below the 144-participant average among 19 other Abdominal Pain trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06381921, a NA study of Abdominal Pain, is actively recruiting participants, sponsored by University of Connecticut.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the treatment of IBS pain via an ambulatory trial.
Primary Outcome
Brief Pain Inventory (BPI) scale: the 9-item scale measures pain intensity and interference using 0 - 10 rating scales. Higher score indicates higher levels of pain intensity and interference.
Conditions Studied
Interventions
- BEHAVIORAL IBS-PPSM intervention
Study Locations (1)
Connecticut
- Vernon Cottage, Depot Campus - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-09-08 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
What NCT06381921 shows while recruiting
NCT06381921 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 144-participant average among 19 other Abdominal Pain trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Abdominal Pain appearing as the primary indexed condition, and to 1 intervention - of which IBS-PPSM intervention is the first listed.
NCT06381921 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06381921 about?
NCT06381921 is a clinical study titled "Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain". The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the...
What is the current status of trial NCT06381921?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09-08. Estimated completion is 2029-02-28.
What conditions does trial NCT06381921 study?
This clinical trial studies the following conditions: Abdominal Pain.
What interventions are being tested in trial NCT06381921?
The interventions under investigation include: IBS-PPSM intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06381921?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06381921 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06381921's enrollment target sits among peer trials
120 9th of 19 higher than 10 of 19 other Abdominal Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GI Alpha-Gal Study
RECRUITING · NA
-
Safety and Efficacy of Carbon Dioxide Gas for Endoscopy
RECRUITING · NA
-
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
RECRUITING · NA
-
Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children
RECRUITING · NA
-
Problem Solving Skills Training For Parent Caregivers of Youth With Chronic Pain
COMPLETED · NA
-
POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI